These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3021326)

  • 21. Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-14-S12-17. PubMed ID: 9331113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
    Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
    Chang AY; Asbury RF; Boros L; Garrow GC; Hsieh S
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):9-12. PubMed ID: 7610399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
    Chang AY; Boros L; Asbury R; Hui L; Rubins J
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
    Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
    Huisman C; Biesma B; Postmus PE; Giaccone G; Schramel FM; Smit EF
    Br J Cancer; 2001 Nov; 85(10):1456-61. PubMed ID: 11720428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of acivicin and cisplatin in non-small-cell lung cancer. A National Cancer Institute of Canada study.
    Maroun JA; Stewart DJ; Verma S; Evans WK; Eisenhauer E
    Am J Clin Oncol; 1990 Oct; 13(5):401-4. PubMed ID: 2171318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
    Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
    Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; DiSaia PJ; Buchsbaum HJ
    Invest New Drugs; 1986; 4(1):49-52. PubMed ID: 3700040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I-II trial of acivicin in adult acute leukemia.
    Powell BL; Craig JB; Capizzi RL; Richards F
    Invest New Drugs; 1988 Apr; 6(1):41-4. PubMed ID: 3165971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I clinical study of quelamycin.
    Brugarolas A; Pachon N; Gosalvez M; Llanderal AP; Lacave AJ; Buesa JM; Marco MG
    Cancer Treat Rep; 1978 Oct; 62(10):1527-34. PubMed ID: 361226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.
    Holoye PY; Dhingra HM; Umsawasdi T; Murphy WK; Carr DT; Lee JS
    Cancer Treat Rep; 1987 Sep; 71(9):859-60. PubMed ID: 2441864
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
    Earhart RH; Khandekar JD; Faraggi D; Schinella RA; Davis TE
    Invest New Drugs; 1989 Jul; 7(2-3):255-60. PubMed ID: 2793383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer.
    Grunberg SM; Itri LM
    Cancer Treat Rep; 1987 Nov; 71(11):1097-8. PubMed ID: 2824046
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II study of caracemide in advanced or recurrent non-small cell lung cancer.
    Belani CP; Eisenberger M; Van Echo D; Hiponia D; Aisner J
    Cancer Treat Rep; 1987 Nov; 71(11):1099-100. PubMed ID: 2824047
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.
    Rose C; Lad TE; Kilton LJ; Schor J; Rosen ST; Rossof AH; Blough RR; Johnson CM
    Invest New Drugs; 1990 Feb; 8(1):97-9. PubMed ID: 2160920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of elsamitrucin in non-small cell lung cancer.
    Goss G; Letendre F; Stewart D; Shepherd F; Schacter L; Hoogendoorn P; Eisenhauer E
    Invest New Drugs; 1994; 12(4):315-7. PubMed ID: 7775132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II trial of oral 4'demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancer.
    Presgrave P; Woods R; Kefford R; Bell D; Raghavan D; Levi J
    Invest New Drugs; 1988 Sep; 6(3):219-21. PubMed ID: 2847993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.